Portfolio company
BrainKey
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an artificial intelligence platform providing three-dimensional brain scan visualisations and neurological health insights for physicians and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
Brainomix
This company develops artificial intelligence imaging platforms for hospitals to automate the diagnosis and treatment of stroke and lung fibrosis.
BrainSpec
This company provides a software platform that processes magnetic resonance spectroscopy data for clinicians and researchers to measure brain chemistry non-invasively.
Hemispheric
This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.
Connectome Health
This company provides brain-imaging scans and an analytics platform for individuals and clinics to monitor cognitive health and performance.
KeywiseAI
This company develops software that monitors smartphone keystroke dynamics to provide cognitive health metrics for individuals and healthcare professionals.
